8 Panel Drug Screen Cup with Adulterants

A CLIA waived, FDA approved advanced compact urine drug test device with a compact-front design for photocopying test results for documentation purposes. The device is completely customizable to any combination of 1-18 drug panels including amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, opiates, and other substances at SAMHSA recommended cut-off levels. It features a screw-lid locking mechanism for leak-proof specimen transportation, a liquid crystal temperature strip for specimen validity testing, and optional built-in adulteration tests for up to six different adulterants. Results are readable within 2-5 minutes with over 99% accuracy.

A CLIA waived, FDA approved advanced mini urine drug test device with a mini-front cylindrical design for documenting test results. The device is completely customizable with 1-18 drug panels from CLIA waived and FDA cleared options including amphetamine, barbiturates, benzodiazepines, buprenorphine, cocaine, methamphetamine, methadone, MDMA, opiates, oxycodone, PCP, propoxyphene, marijuana, and tricyclic antidepressants, with additional forensic use only panels available. It features a screw-lid locking mechanism for leak-proof transportation, an integrated liquid crystal temperature strip for specimen validity testing, optional built-in adulteration testing for up to six different adulterants, and delivers results within 2-5 minutes with over 99% accuracy.

Rapid screening test cups for simultaneous detection of multiple drug metabolites including THC, cocaine, opioids, amphetamines, and benzodiazepines. Used in workplace screening, clinical, and forensic testing applications.

A urine drug test cup using Driven Flow Technology that detects twelve drug analytes (AMP, BAR, BUP, BZD, COC, MET, MOR, MTD, OXI300, PCP, THC, XTC) plus adulteration markers (CR, pH, SH, OX). The screening test is a one-step chromatographic immunoassay that yields results in as little as 2 minutes and maintains line integrity for 2 hours. The kit includes all necessary components for immediate use at room temperature, with internal controls included for test integrity confirmation.

Rapid multi-drug screening test cup for qualitative detection of drug metabolites in urine specimens. Designed for point-of-care testing in clinical, workplace, and forensic settings. Provides quick results with multiple drug panel capability in a single-use format.

Multi-panel rapid immunoassay test cups detecting up to 14 drugs of abuse including amphetamine, barbiturates, benzodiazepines, cocaine, opioids, and THC. Lateral flow technology provides qualitative results for screening and preliminary analysis.

A rapid screening device for detecting multiple drugs of abuse from urine specimens in a single cup format.

Rapid immunoassay test cup detecting 14 drugs of abuse including amphetamine, barbiturates, benzodiazepines, cocaine, methamphetamine, MDMA, morphine, opioids, oxycodone, PCP, THC, ketamine, and methadone. Health Canada and CE certified with ISO 13485:2016 compliance.

A urine-based rapid test cup for the simultaneous screening of multiple drugs of abuse. This integrated device provides point-of-care testing for drug screening in various settings.

Integrated drug screening cups combining collection and testing in a single-use device for workplace and clinical screening. Multi-analyte capable with results visible in specified timeframe.

A urine drug test cup using Driven Flow Technology that detects seven drug analytes (AMP, COC, MET, MOR, PCP, THC, XTC). The screening test is a one-step chromatographic immunoassay that yields results in as little as 2 minutes and maintains line integrity for 2 hours. The kit includes all necessary components for immediate use at room temperature, with internal controls included for test integrity confirmation.

A cup-format test device for simultaneous detection of multiple drugs of abuse in urine. Combines collection and testing in one integrated system for convenient screening.